author-photo

Susi Inglis

Shire plc

8

Papers

22

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

Tu1196 Evaluation of the Pharmacokinetics and Safety of MMX Mesalamine Following Administration in Children and Adolescents With Ulcerative Colitis

2014 Gastroenterology
Show All
- Source
- Cite
- Save
Citations (0)
P394 Pooled clinical trial analysis of MMX mesalazine safety: Focus on 4.8 g/d dose long-term exposure

2014 Journal of Crohns & Colitis
Show All
- Source
- Cite
- Save
Citations (1)
Comparison of Long-term Outcomes of MMX Mesalamine Maintenance Treatment for Ulcerative Colitis (UC) between Patients (Pts) in Complete Remission (CR) and Partial Remission (PR) Following Induction: 1808

2013 The American Journal of Gastroenterology
Show All
- Source
- Cite
- Save
Citations (0)
P349 The effect of ulcerative colitis (UC) remission status after 8 weeks of induction therapy with MMX® mesalazine on long-term maintenance therapy outcomes (MOMENTUM Study): induction phase results

2013 Journal of Crohns & Colitis
Show All
- Source
- Cite
- Save
Citations (0)
The Effect of Ulcerative Colitis (UC) Remission Status After Induction With MMX® Mesalamine on Long-Term Maintenance Therapy Outcomes (MOMENTUM Study): Induction Phase Results Presidential Poster: 1670

2012 The American Journal of Gastroenterology
Show All
- Source
- Cite
- Save
Citations (0)